Internalization of annexin A5-functionalized iron oxide particles by apoptotic Jurkat cells

Contrast Media and Molecular Imaging

Volumn 4, Issue 1, 2009, Pages 24-32

  van Tilborg, Geralda A F ^a   Geelen, Teresa ^a   Duimel, Hans ^b   Bomans, Paul H H ^a,b   Frederik, Peter M ^a,b   Sanders, Honorius M H F ^a   Deckers, Niko M ^c   Deckers, Roel ^a   Reutelingsperger, Chris P M ^c   Strijkers, Gustav J ^a   Nicolay, Klaas ^a  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Annexin A5; Apoptosis; Internalization; Iron oxide; MRI

Indexed keywords

CONTRAST MEDIUM; IRON OXIDE; LIPOCORTIN 5; CALCIUM; DIAGNOSTIC AGENT; FERRIC ION; FERRIC OXIDE; NANOPARTICLE; PHOSPHATIDYLSERINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL FRACTIONATION; CELL MEMBRANE; CELL SPECIFICITY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL CULTURE; IN VITRO STUDY; INTERNALIZATION; LEUKEMIA CELL LINE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BINDING; STIMULUS; TRANSMISSION ELECTRON MICROSCOPY; CHEMISTRY; METABOLISM; ULTRASTRUCTURE;

ANNEXIN A5; APOPTOSIS; CALCIUM; CELL MEMBRANE; CONTRAST MEDIA; FERRIC COMPOUNDS; HUMANS; JURKAT CELLS; NANOPARTICLES; PHOSPHATIDYLSERINES;

EID: 63449100316     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.261     Document Type: Article

References (33)

1. Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993; 341(8855): 1251-1254.
2. Haunstetter A, Izumo S. Future perspectives and potential implications of cardiac myocyte apoptosis. Cardiovasc Res. 2000; 45(3): 795-801.
3. Corsten MF, Hofstra L, Narula J, Reutelingsperger CP. Counting heads in the war against cancer: defining the role of annexin A5 imaging in cancer treatment and surveillance. Cancer Res. 2006; 66(3): 1255-1260.
4. Fadok VA, de Cathelineau A, Daleke DL, Henson PM, Bratton DL. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J. Biol. Chem. 2001; 276(2): 1071-1077.
5. Gerke V, Moss SE. Annexins: from structure to function. Physiol. Rev. 2002; 82(2): 331-371.
6. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998; 31(1): 1-9.
7. Dumont EA, Reutelingsperger CP, Smits JF, et al. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat. Med. 2001; 7(12): 1352-1355.
8. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc. Natl Acad. Sci. USA 1998; 95(11): 6349-6354.
9. Hofstra L, Liem IH, Dumont EA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000; 356(9225): 209-212.
10. Schellenberger EA, Bogdanov A Jr, Hogemann D, et al. Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Mol. Imag. 2002; 1(2): 102-107.
11. Schellenberger EA, Sosnovik D, Weissleder R, Josephson L. Magneto/ Optical annexin v, a multimodal protein. Bioconjug. Chem. 2004; 15(5): 1062-1067.
12. Sosnovik DE, Schellenberger EA, Nahrendorf M, et al. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn. Reson. Med. 2005; 54(3): 718-724.
13. van Tilborg GA, Mulder WJ, Deckers N, et al. Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis. Bioconjug. Chem. 2006; 17(3): 741-749.
14. Schellenberger E, Schnorr J, Reutelingsperger C, et al. Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis. Small 2008; 4(2) 225-230.
15. Jung HI, Kettunen MI, Davletov B, Brindle KM. Detection of apoptosis using the C2A domain of synaptotagmin I. Bioconjug Chem 2004; 15(5): 983-987.
16. Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat. Med. 2001; 7(11): 1241-1244.
17. Prinzen L, Miserus RJJH, Dirksen A, et al. Optical and magnetic resonance imaging of cell death and platelet activation using annexin A5-functionalized quantum dots. Nano Lett. 2007; 7(1): 93-100.
18. van Tilborg GA, Mulder WJ, Chin PT, et al. Annexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multi-modal detection of apoptotic cells. Bioconjug. Chem. 2006; 17(4): 865-868.
19. Neves AA, Krishnan AS, Kettunen MI, et al. A paramagnetic nanoprobe to detect tumor cell death using magnetic resonance imaging. Nano Lett. 2007; 7(5): 1419-1423.
20. Muller RN, Roch A, Colet J, Ouakssim A, Gillis P. Particulate magnetic contrast agents. In The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging, Merbach AE, Toth E (eds). Wiley: Chichester, 2001; 417-435.
21. Perez JM, Josephson L, Weissleder R. Use of magnetic nanoparticles as nanosensors to probe for molecular interactions. Chem-biochem 2004; 5(3): 261-264.
22. Kim GY, Josephson L, Langer R, Cima MJ. Magnetic relaxation switch detection of human chorionic gonadotrophin. Bioconjug. Chem. 2007; 18(6): 2024-2028.
23. Billotey C, Wilhelm C, Devaud M, et al. Cell internalization of anionic maghemite nanoparticles: quantitative effect on magnetic resonance imaging. Magn. Reson. Med. 2003; 49(4): 646-654.
24. Simon GH, Bauer J, Saborovski O, et al. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5 T and 3 T clinical MR scanning. Eur. Radiol. 2006; 16(3): 738-745.
25. Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt BK. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn. Reson. Med. 2002; 48(1): 52-61.
26. 2* mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing. Radiology 2007; 245(2): 449-457.
27. Tanimoto A, Oshio K, Suematsu M, Pouliquen D, Stark DD. Relaxation effects of clustered particles. J. Magn. Reson. Imag. 2001; 14(1): 72-77.
28. Kenis H, van Genderen H, Bennaghmouch A, et al. Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J. Biol. Chem. 2004; 279(50): 52623-52629.
29. Oling F, Santos JSDO, Govorukhina N, et al. Structure of membrane-bound annexin A5 trimers: a hybrid Cryo-EM-X-ray crystallography study. J. Mol. Biol. 2000; 304(4): 561-573.
30. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur. Radiol. 2001; 11(11): 2319-2331.
31. Josephson L, Lewis J, Jacobs P, Hahn PF, Stark DD. The effects of iron oxides on proton relaxivity. Magn. Reson. Imag. 1988; 6(6): 647-653.
32. Dressel R, Elsner L, Quentin T, Walter L, Gunther E. Heat shock protein 70 is able to prevent heat shock-induced resistance of target cells to CTL. J. Immunol. 2000; 164(5): 2362-2371.
33. Deichmann R, Haase A. Quantification of T1 values by snapshot-flash NMR imaging. J. Magn. Reson. 1992; 96(3): 608-612.